Doogan Declan 4
4 · TENAX THERAPEUTICS, INC. · Filed Jul 3, 2025
Insider Transaction Report
Form 4
Doogan Declan
Director
Transactions
- Award
Stock Option (right to buy)
2025-07-01+80,000→ 80,000 totalExercise: $5.75From: 2025-07-01Exp: 2035-07-01→ Common Stock (80,000 underlying)
Holdings
- 4
Stock Option (right to buy)
Exercise: $992.00From: 2023-06-09Exp: 2032-06-09→ Common Stock (4 underlying) - 100,000
Stock Option (right to buy)
Exercise: $5.94From: 2025-12-10Exp: 2034-12-10→ Common Stock (100,000 underlying) - 2,274
Common Stock
- 4
Stock Option (right to buy)
Exercise: $3200.00From: 2022-06-10Exp: 2031-06-10→ Common Stock (4 underlying)